_2d3081a1-1d2c-46d3-a73e-bafcd88a905e_resize.webp)
Mounjaro 2.5mg Solution For Injection 1s
Out of Stock • people bought this
- Improves blood sugar control
- Supports weight loss
- Suppresses appetite
- Once-weekly easy injection
Seller : Davadost pharma private limited
Similar Medicine Of
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to
Mounjaro 2.5mg Solution for Injection is a prescription medication designed to help adults with type 2 diabetes manage their blood sugar levels. It contains Tirzepatide, a dual-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This medication works by enhancing insulin secretion, reducing glucagon production, and slowing gastric emptying, leading to improved blood sugar control. Mounjaro is typically prescribed alongside a healthy diet and regular exercise and is administered once weekly as a subcutaneous injection.
Mounjaro (Tirzepatide) mimics the action of two incretin hormones—GIP and GLP-1—which play a crucial role in regulating blood sugar. It enhances insulin release when blood sugar is high, decreases glucagon secretion (which prevents excess glucose production in the liver), and slows down digestion to reduce spikes in blood sugar after meals. This unique dual-action mechanism helps improve glycemic control in type 2 diabetes patients.
- Mounjaro is administered as a subcutaneous (under the skin) injection once a week.
- It can be injected in the abdomen, thigh, or upper arm.
- The injection should be taken on the same day each week.
- Rotate injection sites to avoid skin irritation.
- Do not use Mounjaro if you have a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
- Patients with severe gastrointestinal issues, such as gastroparesis, should use this medication with caution.
- Regular blood sugar monitoring is essential while using this drug.
- Inform your doctor of any history of pancreatitis, kidney disease, or heart problems before starting treatment.
- Mounjaro 2.5mg improves blood sugar control in type 2 diabetes.
- Helps reduce weight in some patients by suppressing appetite.
- Works through a dual-action mechanism to regulate blood glucose.
- Reduces the risk of diabetes-related complications when combined with diet and exercise. Side Effects Of Mounjaro 2.5mg For Injection 1s
USES IN
- Type 2 Diabetes
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Reduced appetite
- Abdominal discomfort
- Pancreatitis (severe abdominal pain)
- If you miss a dose, take it as soon as possible within four days.
- If more than four days have passed, skip the missed dose and take the next scheduled dose.
- Do not take two doses simultaneously to make up for the missed one.
Health And Lifestyle
- Insulin or other diabetes medications, increasing the risk of hypoglycemia.
- Oral medications, as it may delay absorption.
- Thyroid medications and some antibiotics.
- Avoid excessive alcohol consumption, as it can cause blood sugar fluctuations.
- Avoid caffeine with Tirzepatide as it may increase heart rate.
Type 2 diabetes is a chronic condition that affects how the body processes blood sugar (glucose). It occurs when the body becomes resistant to insulin or doesn't produce enough of it. Symptoms include excessive thirst, frequent urination, fatigue, and slow wound healing. Managing diabetes requires a combination of medication, diet, exercise, and lifestyle changes.
Safety Advice For
- High risk
- Moderate risk
- Safe
Consuming alcohol may increase the risk of low blood sugar (hypoglycemia) and can worsen side effects like nausea and vomiting. It is advisable to avoid or limit alcohol intake.
Mounjaro may harm the developing fetus. Hence, it must not be used in pregnant women.
It is not known whether Mounjaro passes into breast milk. Talk to your doctor about the risks before using this medication.
Mounjaro may cause dizziness or drowsiness, especially when used with other medications that lower blood sugar levels. If you experience these symptoms, avoid driving or operating heavy machinery.
Use Mounjaro cautiously in patients with severe kidney disease. Consult your doctor before use.
Monitor liver function while on Mounjaro. Patients with severe liver conditions should consult their doctor.
- Stick to a consistent meal schedule.
- Choose whole foods over processed foods.
- Monitor blood sugar levels daily.
- Engage in regular physical activity.
- Stay hydrated and practice portion control.
- Active Ingredient: Tirzepatide (2.5mg)
- Used For: Type 2 Diabetes
- Dosage Form: Injection
- Route of Administration: Subcutaneous
- Prescription Required: Yes
Store Mounjaro 2.5mg For Injection 1s in a refrigerator at a temperature between 2°C to 8°C. Do not freeze the medication. Keep it away from direct sunlight and heat to maintain its effectiveness.
- The usual starting dose is 2.5mg once a week, which may be increased based on the doctor’s recommendation.
- Do not change your dose without medical guidance.
Mounjaro 2.5mg Solution for Injection (Tirzepatide) is a breakthrough medication for managing type 2 diabetes. It works through a dual incretin mechanism to improve blood sugar control, suppress appetite, and support weight loss in some patients. This once-weekly injection is an effective addition to a diabetes management plan that includes a healthy diet and exercise.
What is Mounjaro 2.5mg Solution for Injection used for?
How does Mounjaro (Tirzepatide) work?
Is Mounjaro 2.5mg effective for weight loss?
How often should I take Mounjaro 2.5mg?
Can I take Mounjaro if I have type 1 diabetes?
Where should I inject Mounjaro?
What are the common side effects of Mounjaro?
Can Mounjaro cause low blood sugar (hypoglycemia)?
How long does it take for Mounjaro to start working?
Can I take Mounjaro with other diabetes medications?
What foods should I avoid while taking Mounjaro?
Does Mounjaro cause thyroid problems?
What should I do if I experience severe side effects?
Written By
Harsh Thakur
Content Updated on
Tuesday, 18 August, 2026
